<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20251008067556N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-06-08</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Evaluating the effectiveness of Acceptance and Commitment Therapy (ACT) in patients with psoriasis</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of acceptance and commitment therapy (ACT) on improving quality of life, reducing symptoms of anxiety and depression, and enhancing psychological flexibility in patients with psoriasis.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-06-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/86736</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: In this study, participants will be allocated into intervention and control groups using a simple randomization method based on a random numbers table in SPSS software. First, the list of eligible participants will be entered into SPSS software. Then, a random variable with uniform distribution will be generated using the following command:

Compute Random = RV.UNIFORM(0,1)

After generating the random variable, the data will be sorted from the smallest to the largest random number, and participants will be assigned to the intervention and control groups according to the resulting order, Blinding description: Given the nature of the intervention (Acceptance and Commitment Therapy), complete blinding was not feasible, as both the therapist and participants were aware of the type of intervention. However, to minimize bias in the data analysis process, partial (single) blinding was implemented; that is, the individual responsible for data entry and statistical analysis was unaware of group assignments (experimental or control).
Furthermore, participants were not informed about the exact research hypothesis or the expected outcomes to prevent the occurrence of the expectancy effect.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Psoriasis.</hc_freetext>
      <i_freetext>Intervention 1: The intervention group receives Acceptance and Commitment Therapy (ACT) in a face-to-face, group format. The intervention consists of eight 60‑minute group sessions delivered over eight weeks (one session per week). Session content is based on the six core ACT processes and includes: theoretical education, acceptance exercises, cognitive defusion practices, mindfulness exercises for present‑moment awareness, values clarification, values‑based goal setting, and committed action planning with homework assignments. Educational materials include presentation slides, a homework booklet, and simple practice files. The sessions are delivered by a clinical psychologist trained in ACT. To ensure treatment fidelity, sessions are reviewed by a senior researcher or clinical supervisor using a fidelity checklist, and participants’ homework assignments are documented and evaluated. Intervention 2: Control group: The control group receives routine care and does not receive any additional psychological intervention. Routine care includes standard medical follow‑up, general dermatological advice, and prescribed medications provided by the dermatologist. To maintain structural equivalence, the control group receives only minimal contact during the study period (limited to necessary follow‑up calls for scheduling assessments), and no educational or therapeutic sessions are provided. After data collection is completed, participants in the control group are offered a brief educational package on stress management and self‑care if they wish.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is I have not yet decided whether to make the participants’ data file publicly available.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Alireza Azizi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ayatollah Amoli Branch, Islamic Azad University, before Komdereh Village, Kilometer 6, Old Amol-Babol Road, Amol</address>
        <city>Amol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4713655365</zip>
        <telephone>+98 11 3222 3594</telephone>
        <email>name@azizi.a.re</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mahta Abdoli</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ayatollah Amoli Branch, Islamic Azad University, before Komdereh Village, Kilometer 6, Old Amol-Babol Road, Amol</address>
        <city>Amol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4613856348</zip>
        <telephone>+98 11 4324 5937</telephone>
        <email>name@mhta.abdoli98</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosis of psoriasis skin disease according to a physician's diagnosis
Age range between 20-40 years
Reading and writing
The willingness and consent of consciousness to enter the research project</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>40 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Diagnosis of severe psychiatric disorders based on medical records or psychiatrist evaluation.
Receiving concurrent similar psychological interventions at the time of enrollment.
Unwillingness to participate in the study or failure to provide informed consent.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>L40</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Psoriasis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The intervention group receives Acceptance and Commitment Therapy (ACT) in a face-to-face, group format. The intervention consists of eight 60‑minute group sessions delivered over eight weeks (one session per week). Session content is based on the six core ACT processes and includes: theoretical education, acceptance exercises, cognitive defusion practices, mindfulness exercises for present‑moment awareness, values clarification, values‑based goal setting, and committed action planning with homework assignments. Educational materials include presentation slides, a homework booklet, and simple practice files. The sessions are delivered by a clinical psychologist trained in ACT. To ensure treatment fidelity, sessions are reviewed by a senior researcher or clinical supervisor using a fidelity checklist, and participants’ homework assignments are documented and evaluated.</i_keyword>
      <i_keyword>Control group: The control group receives routine care and does not receive any additional psychological intervention. Routine care includes standard medical follow‑up, general dermatological advice, and prescribed medications provided by the dermatologist. To maintain structural equivalence, the control group receives only minimal contact during the study period (limited to necessary follow‑up calls for scheduling assessments), and no educational or therapeutic sessions are provided. After data collection is completed, participants in the control group are offered a brief educational package on stress management and self‑care if they wish.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Quality of life in patients with psoriasis. Timepoint: Before the intervention and after completion of the treatment sessions. Method of measurement: Measured using the Dermatology Life Quality Index (DLQI).</prim_outcome>
      <prim_outcome>Anxiety level in patients with psoriasis. Timepoint: Before the intervention and after completion of the treatment sessions. Method of measurement: Measured using the Anxiety subscale of the Hospital Anxiety and Depression Scale (HADS‑A).</prim_outcome>
      <prim_outcome>Depression level in patients with psoriasis. Timepoint: Before the intervention and after completion of the treatment sessions. Method of measurement: Measured using the Depression subscale of the Hospital Anxiety and Depression Scale (HADS‑D).</prim_outcome>
      <prim_outcome>Cognitive flexibility in patients with psoriasis. Timepoint: Before the intervention and after completion of the treatment sessions. Method of measurement: Measured using the Cognitive Flexibility Inventory (CFI) by Dennis &amp; Vander Wal.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-09-13</approval_date>
        <contact_name>Ethics Committee of Ayatollah Amoli University of Science and Research</contact_name>
        <contact_address>No. 2, Parsa 2 Alley, Rahimi Alley, Emam Reza Street, Amol Amol Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
